Aevis Victoria : 14/09/2023 Half-year Results 2023 Presentation

Transaction

11.1%

Stake acquired by Visana Beteiligungen AG

CHF 2.2bn

Enterprise Value (post-money)

Post-deal financial effect on AEVIS level:

• Pro-formaequity ratio increases to 35.5% (vs. 28.5% in 2022)
• Net debt reduction of CHF 150m decreases pro-forma leverage ratio to 49.5%
  (vs. 54.2% in 2022)

Joint Integrated Care strategy

• Integrated care as a solution for the growing challenges in the Swiss healthcare system
• Nationwide expansion as a next step:
• • Full capitation basic insurance plan VIVA ready to be offered to members as of 2024
  • Ongoing discussions for the establishment of additional integrated care networks
  • Vision: Start at least 5 more clusters within the next 5 years

Swiss Medical Network is optimally positioned to actively shape the future of healthcare:

• Clear Integrated Care strategy (missing link for insurance companies)
• Very experienced and visionary leadership team

AEVIS/SPIX performance comparison

AEVIS SPIX

80%

70%

60%

50%

40%

30%

20%

10%

0% -10%-20%

• AEVIS VICTORIA is listed on the SIX Swiss Exchange (AEVS)
• The shares are part of
• • Swiss Performance Index (SPI)
  • SXI Life Sciences Index (SLIFE) and
  • SXI Bio+Medtech Index (SBIOM)
• All shares are registered shares